PCN299 - A REVIEW OF APPRAISAL TIMELINES IN ONCOLOGY- DOES REIMBURSEMENT THROUGH THE CANCER DRUGS FUND (CDF) DELAY PATIENT ACCESS?
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.381
https://www.valueinhealthjournal.com/article/S1098-3015(18)33681-7/fulltext
Title :
PCN299 - A REVIEW OF APPRAISAL TIMELINES IN ONCOLOGY- DOES REIMBURSEMENT THROUGH THE CANCER DRUGS FUND (CDF) DELAY PATIENT ACCESS?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33681-7&doi=10.1016/j.jval.2018.09.381
First page :
Section Title :
Open access? :
No
Section Order :
2287